These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 32931985)

  • 1. Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review.
    Kilian A; Chock YP; Huang IJ; Graef ER; Upton LA; Khilnani A; Krupnikova SDS; Almaghlouth I; Cappelli LC; Fernandez-Ruiz R; Frankel BA; Frankovich J; Harrison C; Kumar B; Monga K; Vega JAR; Singh N; Sparks JA; Sullo E; Young KJ; Duarte-Garcia A; Putman M; Johnson S; Grainger R; Wallace ZS; Liew JW; Jayatilleke A
    Semin Arthritis Rheum; 2020 Oct; 50(5):1191-1201. PubMed ID: 32931985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
    Misra DP; Agarwal V; Gasparyan AY; Zimba O
    Clin Rheumatol; 2020 Jul; 39(7):2055-2062. PubMed ID: 32277367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments.
    Ouédraogo DD; Tiendrébéogo WJS; Kaboré F; Ntsiba H
    Clin Rheumatol; 2020 Jul; 39(7):2069-2075. PubMed ID: 32472461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR.
    Tam LS; Tanaka Y; Handa R; Chang CC; Cheng YK; Isalm N; Li M; Lorenzo JP; Song YW; Yamamoto K; Zeng X; Haq SA
    Int J Rheum Dis; 2020 Jun; 23(6):717-722. PubMed ID: 32462761
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.
    Ghosh N; Tirpack A; Chan KK; Bass AR
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33067320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.
    Pablos JL; Abasolo L; Alvaro-Gracia JM; Blanco FJ; Blanco R; Castrejón I; Fernandez-Fernandez D; Fernandez-Gutierrez B; Galindo-Izquierdo M; Gonzalez-Gay MA; Manrique-Arija S; Mena Vázquez N; Mera Varela A; Retuerto M; Seijas-Lopez A;
    Ann Rheum Dis; 2020 Sep; 79(9):1170-1173. PubMed ID: 32532753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 in rheumatic disease patients on immunosuppressive agents.
    Sharmeen S; Elghawy A; Zarlasht F; Yao Q
    Semin Arthritis Rheum; 2020 Aug; 50(4):680-686. PubMed ID: 32512263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Navigating COVID-19 in the developing world.
    Hodkinson B; Singh P; Gcelu A; Bautista-Molano W; Pons-Estel G; Alpízar-Rodríguez D
    Clin Rheumatol; 2020 Jul; 39(7):2039-2042. PubMed ID: 32462422
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: a primer for the rheumatologist: management of patients and care settings.
    Calabrese C; Lehman B
    Curr Opin Rheumatol; 2020 Sep; 32(5):429-433. PubMed ID: 32744823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases.
    Gremese E; Ferraccioli ES; Alivernini S; Tolusso B; Ferraccioli G
    Eur J Clin Invest; 2020 Sep; 50(9):e13342. PubMed ID: 32645207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
    Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
    Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical management of Lupus patients during the COVID-19 pandemic.
    Mason A; Rose E; Edwards CJ
    Lupus; 2020 Nov; 29(13):1661-1672. PubMed ID: 33059530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients?
    Morales-Torres J; Aceves-Ávila FJ
    Clin Rheumatol; 2020 Nov; 39(11):3177-3183. PubMed ID: 32889590
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy.
    Quartuccio L; Valent F; Pasut E; Tascini C; De Vita S
    Joint Bone Spine; 2020 Oct; 87(5):439-443. PubMed ID: 32445935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to manage rheumatic patients during the coronavirus pandemic.
    Parisi S; Ditto MC; Finucci A; Fusaro E
    Panminerva Med; 2020 Sep; 62(3):176-177. PubMed ID: 32343511
    [No Abstract]   [Full Text] [Related]  

  • 20. Rheumatology in a time of Coronavirus: lessons from our early experiences.
    Cronin O; Horne A; Ralston SH
    QJM; 2020 Oct; 113(10):715-716. PubMed ID: 32396603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.